Standout Papers
- Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer (1993)
- Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types (2002)
Citation Impact
1 by Nobel laureates 24 from Science/Nature 122 standout
Citing Papers
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Works of Thomas Björk being referenced
Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors.
2003
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types
2002 Standout
Author Peers
| Author | PRM | Rheumatology | Surgery | Oncology | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Thomas Björk | 2016 | 389 | 311 | 778 | 440 | 35 | 2.7k | |
| Yury D. Tretyakov | 1 | 11 | 1 | 20 | 15 | 492 | ||
| Nicole Fowler‐Jaeger | 159 | 2 | 44 | 12 | 387 | 8 | 486 | |
| Gagik Ghazaryan | 2 | 13 | 73 | 14 | 536 | |||
| Florian C. Uecker | 13 | 1 | 59 | 9 | 5 | 36 | 325 | |
| Louisa Salmon | 24 | 2 | 34 | 1 | 10 | 863 |
All Works
Loading papers...